Lichenoid stomatitis associated with lithium carbonate. 1985

D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane

Lichenoid stomatitis has been reported in the use of a number of drugs. This is a case report of lichenoid stomatitis associated with lithium carbonate. The association between lichenoid stomatitis and lithium carbonate was confirmed by rechallenge in this patient. A number of cutaneous reactions have been reported as adverse effects of lithium therapy. Lichenoid reactions are characterized by an infiltrate of T cells. Lithium has been reported to alter T cell function in vitro.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D013280 Stomatitis INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP. Oral Mucositis,Mucositis, Oral,Oromucositis,Mucositides, Oral,Oral Mucositides,Oromucositides,Stomatitides
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
June 1978, JAMA,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
July 1992, BMJ (Clinical research ed.),
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
January 1995, Annales de dermatologie et de venereologie,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
October 1972, The New England journal of medicine,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
May 1980, JAMA,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
January 1954, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
July 1982, Postgraduate medical journal,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
February 1981, Archives of internal medicine,
D J Hogan, and F Murphy, and W R Burgess, and J D Epstein, and P R Lane
April 1970, Canadian Psychiatric Association journal,
Copied contents to your clipboard!